Cardiovascular Syst (CSII) 19.50 $CSII Cardiovascular

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cardiovascular Syst (CSII) 19.50 $CSII

Cardiovascular Systems Up 88.6% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri Jul 29, 12:13AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 5 months, Cardiovascular Systems has returned 88.61% as of today's recent price of $19.30.
CSII: 19.50 (-0.11)

Uptrend Call Working As Cardiovascular Systems Stock Rises 86.6% (CSII)
Comtex SmarTrend(R) - Thu Jul 14, 12:11AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 86.61% as of today's recent price of $19.09.
CSII: 19.50 (-0.11)

Cardiovascular Systems Seeks Device Approval in Japan
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 7:49AM CDT
On receiving the approval, Japan will become the first international market to offer a product of Cardiovascular Systems (CSII).
HCM: 13.19 (+0.06), CSII: 19.50 (-0.11), GWPH: 96.11 (+1.79), NUVA: 63.29 (+1.09)

Cardiovascular Systems Submits Diamondback 360(R) Coronary Orbital Atherectomy System Micro Crown for Approval in Japan
BusinessWire - Wed Jul 06, 3:05PM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that it has submitted an application to Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for approval of its Diamondback 360(R) Coronary Orbital Atherectomy System (OAS) Micro Crown to treat severely calcified coronary arteries for the facilitation of stent placement.
CSII: 19.50 (-0.11)

84.8% Return Seen to Date on SmarTrend Cardiovascular Systems Call (CSII)
Comtex SmarTrend(R) - Wed Jul 06, 12:44PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 84.75% as of today's recent price of $18.90.
CSII: 19.50 (-0.11)

Cardiovascular Systems Has Returned 66.0% Since SmarTrend Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 21, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 65.98% as of today's recent price of $16.98.
CSII: 19.50 (-0.11)

Cardiovascular Systems Shares Up 78.3% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 14, 12:12AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 78.30% as of today's recent price of $18.24.
CSII: 19.50 (-0.11)

FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility
PR Newswire - Fri Jun 10, 10:30AM CDT
Terumo Cardiovascular Systems (Terumo CVS) received notice from the U.S. Food and Drug Administration (FDA) that it has successfully completed the second and final phase of its work plan to remediate all products manufactured or distributed from Terumo's Ann Arbor, Michigan manufacturing facility, including Terumo® Advanced Perfusion System 1. As a result, all shipping restrictions, imposed as a term of its 2011 consent decree, are now lifted.
CSII: 19.50 (-0.11)

Cardiovascular Systems Up 70.3% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri May 27, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 70.28% as of today's recent price of $17.42.
CSII: 19.50 (-0.11)

Cardiovascular Systems Shares Up 42.4% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Thu May 12, 1:03PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 42.42% as of today's recent price of $14.57.
CSII: 19.50 (-0.11)

Updated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc.
PR Newswire - Thu May 12, 12:07PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Cardiovascular Systems, Inc. ("CSII" or the "Company" (NASDAQ: CSII), concerning whether the board has breached its fiduciary duties to shareholders.
CSII: 19.50 (-0.11)

Cardiovascular (CSII) Narrows Loss in Q3, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:36AM CDT
Cardiovascular Systems Inc. (CSII) reported third-quarter fiscal 2016 adjusted net loss per share of 31 cents.
CAPR: 3.58 (-0.12), CSII: 19.50 (-0.11), BAX: 48.50 (+0.48), CRDC: 2.35 (-0.15)

Cardiovascular Systems Shares Final Three-Year ORBIT II Results at 2016 Society for Cardiovascular Angiography and Interventions Annual Meeting
BusinessWire - Thu May 05, 7:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Florida.
CSII: 19.50 (-0.11)

Shares of CSII Up 33.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 05, 12:54AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 33.63% as of today's recent price of $13.67.
CSII: 19.50 (-0.11)

Cardiovascular Systems reports 3Q loss
Automated Insights - Wed May 04, 5:06PM CDT
ST. PAUL, Minn. (AP) _ Cardiovascular Systems Inc. (CSII) on Wednesday reported a loss of $22.7 million in its fiscal third quarter.
CSII: 19.50 (-0.11)

Cardiovascular Systems Reports Fiscal 2016 Third-Quarter Financial Results
BusinessWire - Wed May 04, 3:05PM CDT
--Revenues of $44.5 million grew 7% from second quarter of fiscal 2016
CSII: 19.50 (-0.11)

Abaxis (ABAX) Q4 Earnings Beat Estimates; Dividend Raised
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 9:21AM CDT
Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2016 earnings per share (EPS) of 36 cents from continuing operations.
BSX: 24.43 (+0.15), CAPR: 3.58 (-0.12), CSII: 19.50 (-0.11), ABAX: 49.14 (-0.32)

NuVasive (NUVA) Tops Q1 Earnings, Grows Internationally
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 11:03AM CDT
NuVasive, Inc. (NUVA) reported first-quarter 2016 adjusted earnings per share (EPS) of 32 cents.
BSX: 24.43 (+0.15), CSII: 19.50 (-0.11), STJ: 83.73 (+0.69), NUVA: 63.29 (+1.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 38

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Sokin’s UAE License Turns Expansion Into Real Payments Plumbing

Updated Category News Views 40

Dubai expansion headlines are cheap; regulated local money movement is not. That is why Sokin’s newly approved Dubai Financial Services Authority license deserves more than the usual fintech applause line. The company has paired that approval with AED accounts, local payment rails, a One Za’abeel office and a plan to double its UAE staff over the next year. None of...

Continue Reading
Palm Beach Loan Company Tests Luxury Lending Demand

Updated Category News Views 162

Jewelry in a safe is dead capital until somebody lends against it. That plain fact sits behind Luxury Asset Capital's latest move: the launch of Palm Beach Loan Company, a South Florida brand aimed at wealthy owners of watches, diamonds, art, handbags, gold, collectibles, and other high-value possessions. The company is not asking clients to sell the stuff they spent...

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 0

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading
Boat Market Forecast Puts Services in the Driver’s Seat

Updated Category News Views 51

A jet ski is not exactly a sober economic indicator, yet the water is telling a useful story. MarketsandMarkets projects the global recreational boat market will rise from $31.38 billion in 2026 to $48.06 billion in 2033, a 6.3% compound annual growth rate. That is respectable growth for a costly discretionary category that got knocked around by softer purchasing activity...

Continue Reading
Cold-Season Cleaning Advice Has a Practical Catch!

Updated Category News Views 11

Remote Controls Are Nobody’s First Suspect A television remote can make the rounds all evening and never see a cloth, which is precisely why Maid Brigade’s cold-and-flu-season reminder lands as common sense rather than revelation. The Scottsdale cleaning company is telling households to look past the usual kitchen counter and bathroom sink routine. Fair enough. People...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 54

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Why Lear’s PACE Award Matters Beyond Seat Warmers Today

Updated Category News Views 0

Seat foam and wiring seldom make investors sit upright, yet Lear has managed to turn that unglamorous corner of the vehicle into something worth watching. The company’s Modular Thermal Comfort Systems just won a 2026 Automotive News PACE Award, a respected supplier-industry nod for innovation and business performance. Awards alone do not pay anybody’s bills, and I...

Continue Reading
Wallstreet Sand Hands Its Massive Permian Plant to Wilbanks

Updated Category News Views 22

A sand plant can brag about acreage and horsepower all day, but frac crews remember who kept material arriving when a completion schedule got ugly. That is the real backdrop to PI Holdings and Wallstreet Sand Co. naming Blaine Wilbanks president of both businesses on November 18, 2026. This is not a ceremonial chair swap. Wallstreet has built an enormous Permian sand...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 204

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading

Top 5 Most Recently Viewed Articles

Siton Mining Leads Global Cloud Mining Revolution Amid XRP Surge

Updated Category News Views 209

XRP Makes Waves in the Cryptocurrency Market The cryptocurrency market is no stranger to volatility, but recent events have made headlines globally. XRP has soared past the $3.6 mark, capturing the attention of investors eager for a piece of this booming digital asset. The crypto sphere is evolving rapidly, and this surge reflects a momentous shift in the financial...

Continue Reading
Amgen's UPLIZNA Shows Great Promise for Myasthenia Gravis

Updated Category News Views 139

Amgen’s UPLIZNA Demonstrates Promise in Myasthenia Gravis Trials Amgen (NASDAQ: AMGN) has recently announced encouraging results from its Phase 3 MINT trial involving UPLIZNA (inebilizumab-cdon), aimed at treating adults with generalized myasthenia gravis (gMG). These findings were unveiled at a prominent conference, demonstrating substantial improvements in the daily...

Continue Reading
Waterton and The NRP Group Expand Luxury Rental Market

Updated Category News Views 371

Strategic Partnership for Luxury Living Waterton, a well-known real estate investor, has collaborated with The NRP Group, a leader in multifamily housing development, to create an exciting rental community just south of the Las Vegas Strip. The new project will feature 368 luxury units designed to provide modern amenities and greater access to employment opportunities in...

Continue Reading
KinderCare Learning IPO Faces Serious Allegations and Investor Impact

Updated Category News Views 211

Investigation into KinderCare Learning's IPO and Allegations KinderCare Learning Companies, Inc. (KLC) is currently facing a significant legal challenge as a securities class action lawsuit has been filed alleging serious issues related to the company's recent IPO. This legal battle, known as Gollapalli v. KinderCare Learning Companies, Inc., et al., raises questions not...

Continue Reading
NovaMeme Emerges with Strategic Partnership for Growth

Updated Category News Views 235

NovaMeme Rebrands and Partners with Toobit for Expansion NovaSeeds has officially transformed into NovaMeme, marking a pivotal shift aimed at enhancing the crypto trading landscape. This rebranding aligns seamlessly with their strategic collaboration with Toobit, a well-respected centralized exchange renowned for its comprehensive crypto trading services including Spot...

Continue Reading